You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
隴神戎發(300534.SZ):七味温陽膠囊獲得新加坡註冊備案許可
格隆匯 03-11 16:33

格隆匯3月11日丨隴神戎發(300534.SZ)公佈,公司全資子公司甘肅新絲路產業投資有限公司收到通知,獲悉公司藥品七味温陽膠囊獲得新加坡共和國註冊備案許可,公司藥品七味温陽膠囊可以正式出口至新加坡共和國並允許開展銷售。

註冊產品名稱:七味温陽膠囊 QIWEI WANGYANG JIAONANG。上述藥品獲得了新加坡國家註冊備案許可,這是本公司產品七味温陽膠囊2017年11月以生物活性添加劑形式在俄羅斯聯邦國家獲得註冊證書後,再次在國外市場以藥品形式拿到註冊備案許可,標誌着七味温陽膠囊可以正式出口至新加坡共和國並允許開展銷售。

七味温陽膠囊主要功能為補腎温陽,益精養血。適用於中老年由腎陽虛引起的腰膝痠軟,畏寒肢冷,頭暈耳鳴,夜尿頻數等症。

此次公司藥品七味温陽膠囊獲得新加坡共和國註冊備案許可標誌着公司可以正式出口至新加坡市場銷售上述產品的資格,將對公司拓展市場帶來積極影響,公司後續將積極推動上述產品在新加坡上市銷售的準備工作。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account